Search results
Down 44.4% in 4 Weeks, Here's Why Infinity (INFI) Looks Ripe for a Turnaround
Zacks via Yahoo Finance· 1 year agoThe heavy selling pressure might have exhausted for Infinity (INFI) as it is technically in oversold...
Infinity Pharma (INFI) Stock Up on Advancing Cancer Study
Zacks via Yahoo Finance· 9 months agoInfinity Pharma (INFI) provides insights on the phase II MARIO-8 study design. The study will...
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoInfinity (INFI) delivered earnings and revenue surprises of 7.14% and 1.63%, respectively, for the...
How Many Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Shares Do Institutions Own?
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) should be aware of the most powerful...
A number of insiders bought Infinitum Copper Corp. (CVE:INFI) stock last year, which is great news...
Simply Wall St. via Yahoo Finance· 12 months agoWhen a single insider purchases stock, it is typically not a major deal. However, when multiple...
Investors in Infinity Pharmaceuticals (NASDAQ:INFI) have unfortunately lost 58% over the last year
Simply Wall St. via Yahoo Finance· 2 years agoIt is doubtless a positive to see that the Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) share price...
Infinity Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 year agoInfinity Pharmaceuticals (NASDAQ:INFI) Third Quarter 2022 Results Key Financial Results Net loss:...
The past five years for Infinity Pharmaceuticals (NASDAQ:INFI) investors has not been profitable
Simply Wall St. via Yahoo Finance· 1 year agoStatistically speaking, long term investing is a profitable endeavour. But along the way some stocks...
Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know
Zacks via Yahoo Finance· 1 year agoInfinity (INFI) doesn't possess the right combination of the two key ingredients for a likely...
Infinity Pharma Posts 52% Increase In One-Year Progression Free Survival Rate In Breast Cancer...
Benzinga via Yahoo Finance· 1 year agoInfinity Pharmaceuticals Inc (NASDAQ: INFI) reported an update from its MARIO-3 study of eganelisib...